BlackRock Advisors’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $948K | Buy |
1,181
+97
| +9% | +$77.9K | ﹤0.01% | 1831 |
|
|
2016
Q3 | $915K | Buy |
1,084
+34
| +3% | +$28.7K | ﹤0.01% | 1815 |
|
|
2016
Q2 | $865K | Buy |
1,050
+27
| +3% | +$22.2K | ﹤0.01% | 1789 |
|
|
2016
Q1 | $1.14M | Buy |
1,023
+23
| +2% | +$25.6K | ﹤0.01% | 1638 |
|
|
2015
Q4 | $1.25M | Buy |
1,000
+222
| +29% | +$277K | ﹤0.01% | 1591 |
|
|
2015
Q3 | $1.05M | Sell |
778
-91
| -10% | -$123K | ﹤0.01% | 1634 |
|
|
2015
Q2 | $1.57M | Buy |
869
+459
| +112% | +$827K | ﹤0.01% | 1349 |
|
|
2015
Q1 | $663K | Buy |
410
+82
| +25% | +$133K | ﹤0.01% | 1836 |
|
|
2014
Q4 | $249K | Sell |
328
-36
| -10% | -$27.3K | ﹤0.01% | 2454 |
|
|
2014
Q3 | $144K | Sell |
364
-6
| -2% | -$2.37K | ﹤0.01% | 2768 |
|
|
2014
Q2 | $224K | Sell |
370
-44
| -11% | -$26.6K | ﹤0.01% | 2531 |
|
|
2014
Q1 | $284K | Buy |
414
+31
| +8% | +$21.3K | ﹤0.01% | 2417 |
|
|
2013
Q4 | $249K | Buy |
383
+79
| +26% | +$51.4K | ﹤0.01% | 2501 |
|
|
2013
Q3 | $180K | Hold |
304
| – | – | ﹤0.01% | 2608 |
|
|
2013
Q2 | $96K | Buy |
+304
| New | +$96K | ﹤0.01% | 2918 |
|